Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Recs

0
Player Avatar StKitt (99.57) Submitted: 8/13/2010 1:42:08 PM : Outperform Start Price: $4.40 ALTH Score: -87.34

Trading at a 52-week low.

Report this Post Reply

Featured Broker Partners


Advertisement